Aqua Pharmaceuticals, An Almirall Company

Aqua Pharmaceuticals, An Almirall Company company information, Employees & Contact Information

Aqua Pharmaceuticals is a specialty dermatology company focusing on acquiring, developing and marketing prescription medical dermatology products in the United States. Currently marketed products include: ACTICLATE® (doxycycline hyclate USP) Tablets, CORDRAN® (flurandrenolide USP) Lotion, Cream, and Ointment, 0.05%, FLUOROPLEX® (fluorouracil) 1% Topical Cream, XOLEGEL® (ketaconazole) Gel, 2%, VERDESO® (desonide) Foam, 0.05%, and MONODOX® (doxycycline monohydrate) Capsules. An essential element in Aqua's strategy for strong, sustainable growth is to build beyond the current product portfolio by developing, licensing, and acquiring products for the treatment of skin conditions. Importantly, Aqua looks to expand its opportunities through product development, in-licensing, co-promotion, product or company acquisition, and partnerships. In December 2013, Almirall S.A. entered into a definitive agreement to acquire Aqua Pharmaceuticals. Almirall is a pharmaceutical company committed to provide valuable medicines through its own R&D efforts together with external partnerships, licenses, and collaborations. Through seeking innovative medicines, Almirall aims to be a relevant player in dermatology, in addition to having a strong interest in gastroenterology and pain. With more than 3,000 employees in 23 countries, Almirall generated total revenues of €825 million in 2013. The company was founded in 1943 and is headquartered in Barcelona, Spain. The stock is traded on the Spanish stock exchange (ticker: ALM).

Company Details

Employees
56
Founded
-
Address
707 Eagleview Blvd,
Phone
6106447000
Email
ca****@****arm.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Exton, PA
Looking for a particular Aqua Pharmaceuticals, An Almirall Company employee's phone or email?

Aqua Pharmaceuticals, An Almirall Company Questions

News

Suresh Kalra appointed CEO of Aquapharm Chemical - Indian Chemical News

Suresh Kalra appointed CEO of Aquapharm Chemical Indian Chemical News

PCBL to acquire water treatment firm Aquapharm - Chemical & Engineering News

PCBL to acquire water treatment firm Aquapharm Chemical & Engineering News

India’s carbon black maker PCBL to acquire Aquapharm Chemicals for Rs38bn - ICIS

India’s carbon black maker PCBL to acquire Aquapharm Chemicals for Rs38bn ICIS

Chemicals major PCBL plans to acquire Pune-based Aquapharm Chemicals for ₹3,800 crore - Mint

Chemicals major PCBL plans to acquire Pune-based Aquapharm Chemicals for ₹3,800 crore Mint

PCBL board okays buyout of Aquapharm Chemicals for Rs 3,800 crore - Business Standard

PCBL board okays buyout of Aquapharm Chemicals for Rs 3,800 crore Business Standard

Dorf-Ketal leads race to acquire Aquapharm Chemicals - VCCircle

Dorf-Ketal leads race to acquire Aquapharm Chemicals VCCircle

PCBL announced acquisition of Aquapharm Chemicals for Rs 3,800 Crore - Siliconindia

PCBL announced acquisition of Aquapharm Chemicals for Rs 3,800 Crore Siliconindia

Sanjiv Goenka group co PCBL to buy Aquapharm - Times of India

Sanjiv Goenka group co PCBL to buy Aquapharm Times of India

PCBL to acquire specialty chemicals company Aquapharm Chemicals for ₹3,800 crore - BusinessLine

PCBL to acquire specialty chemicals company Aquapharm Chemicals for ₹3,800 crore BusinessLine

Dorf-Ketal Frontrunner To Acquire Aquapharm, To Raise Rs 3,800 Cr - outlookbusiness.com

Dorf-Ketal Frontrunner To Acquire Aquapharm, To Raise Rs 3,800 Cr outlookbusiness.com

RPG Group, Bain Capital, Dorf Ketal in race to buy a stake in Aquapharm Chemicals - Business Outreach Magazine

RPG Group, Bain Capital, Dorf Ketal in race to buy a stake in Aquapharm Chemicals Business Outreach Magazine

PCBL shares gain 3% on buying Aquapharm Chemicals for Rs 3,800 crore - Moneycontrol

PCBL shares gain 3% on buying Aquapharm Chemicals for Rs 3,800 crore Moneycontrol

PCBL To Acquire Aquapharm Chemicals for Rs3,800 Crore - Moneylife

PCBL To Acquire Aquapharm Chemicals for Rs3,800 Crore Moneylife

Aquapharm in talks to sell stake for ₹5k crore - Mint

Aquapharm in talks to sell stake for ₹5k crore Mint

PCBL to acquire Aquapharm Chemicals for Rs. 3800 Cr - Indian Chemical News

PCBL to acquire Aquapharm Chemicals for Rs. 3800 Cr Indian Chemical News

RP-Sanjiv Goenka, Bain Capital, Dorf Ketal in race to acquire Aquapharm - Moneycontrol

RP-Sanjiv Goenka, Bain Capital, Dorf Ketal in race to acquire Aquapharm Moneycontrol

RP-Sanjiv Goenka Group's PCBL to acquire Aquapharm Chemicals for ₹3,800 cr - Mint

RP-Sanjiv Goenka Group's PCBL to acquire Aquapharm Chemicals for ₹3,800 cr Mint

PCBL gets CCI approval to acquire Aquapharm Chemicals - The Economic Times

PCBL gets CCI approval to acquire Aquapharm Chemicals The Economic Times

PCBL board okays buyout of Pune-based Aquapharm Chemicals for ₹3,800 crore - CNBC TV18

PCBL board okays buyout of Pune-based Aquapharm Chemicals for ₹3,800 crore CNBC TV18

RP-Sanjiv Goenka, Bain Capital, Dorf Ketal looking to buy Pune-based AquaPharm Chemicals - Business Today

RP-Sanjiv Goenka, Bain Capital, Dorf Ketal looking to buy Pune-based AquaPharm Chemicals Business Today

Bertrand Lehuu joins Aquapharm - Pharmafile

Bertrand Lehuu joins Aquapharm Pharmafile

Top Aqua Pharmaceuticals, An Almirall Company Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant